末梢动脉栓塞防止设备的开发平台 - 开发阶段，市场区隔，地区和国家，法规途径，主要企业(2023年)

本报告提供末梢动脉栓塞防止设备的开发中产品调查分析，提供包含各开发阶段的产品的比较分析，及进行中的临床试验的资料之全面性资讯。

目录

第1章 目录

第2章 简介

第3章 开发中的产品

• 末梢动脉栓塞防止设备 - 开发中产品:各开发阶段
• 末梢动脉栓塞防止设备 - 开发中产品:各市场区隔
• 末梢动脉栓塞防止设备 - 开发中产品:各地区
• 末梢动脉栓塞防止设备 - 开发中产品:各法规途径
• 末梢动脉栓塞防止设备 - 开发中产品:各估计核准日
• 末梢动脉栓塞防止设备 - 进行中的临床试验

第4章 末梢动脉栓塞防止设备 - 正在开发的开发中产品:各企业

• 末梢动脉栓塞防止设备企业 - 开发中产品:各开发阶段
• 末梢动脉栓塞防止设备 - 开发中产品:各开发阶段

第5章 末梢动脉栓塞防止设备的企业和产品概要

• Abbott Vascular Inc:企业概要
  • Abbott Vascular Inc:开发中产品和进行中的临床试验概要
• AorticLab Sarl:企业概要
  • AorticLab Sarl:开发中产品和进行中的临床试验概要
• APT Medical Inc:企业概要
  • APT Medical Inc:开发中产品和进行中的临床试验概要
• Artio Medical:企业概要
  • Artio Medical:开发中产品和进行中的临床试验概要
• Avantec Vascular Corp:企业概要
  • Avantec Vascular Corp:开发中产品和进行中的临床试验概要
• Cardio-Flow Ltd.:企业概要
  • Cardio-Flow Ltd.:开发中产品和进行中的临床试验概要
• Cardiovascular Systems Inc:企业概要
  • Cardiovascular Systems Inc:开发中产品和进行中的临床试验概要
• Emboline, Inc.:企业概要
  • Emboline, Inc.:开发中产品和进行中的临床试验概要
• Ev3 Inc:企业概要
  • Ev3 Inc:开发中产品和进行中的临床试验概要
• Filterlex Medical Ltd:企业概要
  • Filterlex Medical Ltd:开发中产品和进行中的临床试验概要
• HeMo Bioengineering Ltd:企业概要
  • HeMo Bioengineering Ltd:开发中产品和进行中的临床试验概要
• Innovative Cardiovascular Solutions, LLC:企业概要
  • Innovative Cardiovascular Solutions, LLC:开发中产品和进行中的临床试验概要
• Innovia LLC:企业概要
  • Innovia LLC:开发中产品和进行中的临床试验概要
• Instylla Inc:企业概要
  • Instylla Inc:开发中产品和进行中的临床试验概要
• Javelin Medical Ltd:企业概要
  • Javelin Medical Ltd:开发中产品和进行中的临床试验概要
• Keystone Heart Ltd:企业概要
  • Keystone Heart Ltd:开发中产品和进行中的临床试验概要
• Marblehead Medical LLC:企业概要
  • Marblehead Medical LLC:开发中产品和进行中的临床试验概要
• MicroPort CardioFlow Medtech Corp:企业概要
  • MicroPort CardioFlow Medtech Corp:开发中产品和进行中的临床试验概要
• MicroPort Scientific Corp:企业概要
  • MicroPort Scientific Corp:开发中产品和进行中的临床试验概要
• MIV Therapeutics Inc:企业概要
  • MIV Therapeutics Inc:开发中产品和进行中的临床试验概要
• Neurosonix Ltd.:企业概要
  • Neurosonix Ltd.:开发中产品和进行中的临床试验概要
• NewMed Medical Co Ltd:企业概要
  • NewMed Medical Co Ltd:开发中产品和进行中的临床试验概要
• Protembis GmbH:企业概要
  • Protembis GmbH:开发中产品和进行中的临床试验概要
• University of Minnesota:企业概要
  • University of Minnesota:开发中产品和进行中的临床试验概要

第6章 末梢动脉栓塞防止设备 - 最近的发展

第7章 附录

Abstract

GlobalData's Medical Devices sector report, "Peripheral Embolic Protection Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" provides comprehensive information about the Peripheral Embolic Protection Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Embolic Protection Device(s) EPDs are used to capture and remove plaque debris that are dislodged during interventional procedures.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

• Extensive coverage of the Peripheral Embolic Protection Devices under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Peripheral Embolic Protection Devices and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of Peripheral Embolic Protection Devices under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2 Introduction

• 2.1 Peripheral Embolic Protection Devices Overview

3 Products under Development

• 3.1 Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development
• 3.2 Peripheral Embolic Protection Devices - Pipeline Products by Segment
• 3.3 Peripheral Embolic Protection Devices - Pipeline Products by Territory
• 3.4 Peripheral Embolic Protection Devices - Pipeline Products by Regulatory Path
• 3.5 Peripheral Embolic Protection Devices - Pipeline Products by Estimated Approval Date
• 3.6 Peripheral Embolic Protection Devices - Ongoing Clinical Trials

4 Peripheral Embolic Protection Devices - Pipeline Products under Development by Companies

• 4.1 Peripheral Embolic Protection Devices Companies - Pipeline Products by Stage of Development
• 4.2 Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development

5 Peripheral Embolic Protection Devices Companies and Product Overview

• 5.1 Abbott Vascular Inc Company Overview
  • 5.1.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.2 AorticLab Sarl Company Overview
  • 5.2.1 AorticLab Sarl Pipeline Products & Ongoing Clinical Trials Overview
• 5.3 APT Medical Inc Company Overview
  • 5.3.1 APT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.4 Artio Medical Company Overview
  • 5.4.1 Artio Medical Pipeline Products & Ongoing Clinical Trials Overview
• 5.5 Avantec Vascular Corp Company Overview
  • 5.5.1 Avantec Vascular Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.6 Cardio-Flow Ltd. Company Overview
  • 5.6.1 Cardio-Flow Ltd. Pipeline Products & Ongoing Clinical Trials Overview
• 5.7 Cardiovascular Systems Inc Company Overview
  • 5.7.1 Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.8 Emboline, Inc. Company Overview
  • 5.8.1 Emboline, Inc. Pipeline Products & Ongoing Clinical Trials Overview
• 5.9 Ev3 Inc Company Overview
  • 5.9.1 Ev3 Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.10 Filterlex Medical Ltd Company Overview
  • 5.10.1 Filterlex Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.11 HeMo Bioengineering Ltd Company Overview
  • 5.11.1 HeMo Bioengineering Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.12 Innovative Cardiovascular Solutions, LLC Company Overview
  • 5.12.1 Innovative Cardiovascular Solutions, LLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.13 Innovia LLC Company Overview
  • 5.13.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.14 Instylla Inc Company Overview
  • 5.14.1 Instylla Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.15 Javelin Medical Ltd Company Overview
  • 5.15.1 Javelin Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.16 Keystone Heart Ltd Company Overview
  • 5.16.1 Keystone Heart Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.17 Marblehead Medical LLC Company Overview
  • 5.17.1 Marblehead Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.18 MicroPort CardioFlow Medtech Corp Company Overview
  • 5.18.1 MicroPort CardioFlow Medtech Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.19 MicroPort Scientific Corp Company Overview
  • 5.19.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.20 MIV Therapeutics Inc Company Overview
  • 5.20.1 MIV Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.21 Neurosonix Ltd. Company Overview
  • 5.21.1 Neurosonix Ltd. Pipeline Products & Ongoing Clinical Trials Overview
• 5.22 NewMed Medical Co Ltd Company Overview
  • 5.22.1 NewMed Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.23 Protembis GmbH Company Overview
  • 5.23.1 Protembis GmbH Pipeline Products & Ongoing Clinical Trials Overview
• 5.24 University of Minnesota Company Overview
  • 5.24.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview

6 Peripheral Embolic Protection Devices- Recent Developments

• 6.1 May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023
• 6.2 May 03, 2023: Inari Medical reports First Quarter 2023 financial results
• 6.3 Apr 26, 2023: MicroPort announces annual results for 2022
• 6.4 Apr 13, 2023: Inari Medical to Announce First Quarter 2023 Financial Results
• 6.5 Apr 12, 2023: Medtronic has a layoff in California
• 6.6 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company
• 6.7 Feb 27, 2023: Inari Medical Reports Fourth Quarter and Full Year 2022 Financial Results
• 6.8 Feb 07, 2023: Inari Medical to Announce Fourth Quarter and Full Year 2022 Financial Results
• 6.9 Jan 31, 2023: Inari Medical to Participate Virtually at the BTIG MedTech Digital Health Life Science & Diagnostic Tools Conference
• 6.10 Jan 10, 2023: Fluidx unveils new embolic for neurovascular use
• 6.11 Jan 10, 2023: Inari Medical Announces Preliminary 2022 Revenue and 2023 Guidance
• 6.12 Dec 08, 2022: Edwards Lifesciences Announces CEO Succession Plan
• 6.13 Nov 23, 2022: Medtronic Reports Quarterly Earnings
• 6.14 Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results
• 6.15 Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday
• 6.16 Nov 02, 2022: Inari Medical Reports Third Quarter 2022 Financial Results
• 6.17 Oct 20, 2022: Edwards Lifesciences to Host Earnings Conference Call on October 27, 2022
• 6.18 Oct 06, 2022: Inari Medical to Announce Third Quarter 2022 Financial Results
• 6.19 Sep 07, 2022: Medtronic to appear at September investor conferences
• 6.20 Aug 23, 2022: Medtronic reports first quarter fiscal 2023 financial results
• 6.21 Aug 23, 2022: Medtronic Announces Quarterly Earnings Results
• 6.22 Aug 16, 2022: Boston Scientific Announces Upcoming Conference Schedule
• 6.23 Aug 03, 2022: Inari Medical Announces Leadership Succession Plan
• 6.24 Aug 03, 2022: Inari Medical Reports Second Quarter 2022 Financial Results
• 6.25 Jul 21, 2022: Edwards Lifesciences to Host Earnings Conference Call on July 28, 2022
• 6.26 Jul 18, 2022: Inari Medical to Announce Second Quarter 2022 Financial Results

7 Appendix

• 7.1 Methodology
• 7.2 About GlobalData
• 7.3 Contact Us
• 7.4 Disclaimer

List of Tables

List of Tables

• Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development
• Peripheral Embolic Protection Devices - Pipeline Products by Segment
• Peripheral Embolic Protection Devices - Pipeline Products by Territory
• Peripheral Embolic Protection Devices - Pipeline Products by Regulatory Path
• Peripheral Embolic Protection Devices - Pipeline Products by Estimated Approval Date
• Peripheral Embolic Protection Devices - Ongoing Clinical Trials
• Peripheral Embolic Protection Devices Companies - Pipeline Products by Stage of Development
• Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development
• Glossary

List of Figures

List of Figures

• Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development
• Peripheral Embolic Protection Devices - Pipeline Products by Segment
• Peripheral Embolic Protection Devices - Pipeline Products by Territory
• Peripheral Embolic Protection Devices - Pipeline Products by Regulatory Path
• Peripheral Embolic Protection Devices - Pipeline Products by Estimated Approval Date
• Peripheral Embolic Protection Devices - Ongoing Clinical Trials